Neurocysticercosis: an update on diagnosis, treatment, and prevention

Roberto Pineda-Reyes, A. Clinton White

Research output: Contribution to journalReview articlepeer-review


Neurocysticercosis (NCC) is an important cause of neurological disease worldwide, including imported cases in nonendemic countries.Purpose of reviewThe purpose of this review is to update information on diagnosis, management, and prevention of neurocysticercosisRecent findingsWHO and Infectious Diseases Society of America/American Society of Tropical Medicine and Hygiene guidelines emphasize the importance of corticosteroids and antiparasitic drugs for viable parenchymal disease and single enhancing lesions. Subarachnoid NCC is associated with a high fatality rate unless optimally treated. Advances in subarachnoid NCC include use of prolonged antiparasitic and anti-inflammatory courses and the increasing use of antigen-detection and quantitative PCR assays in diagnosis and follow-up. Emerging data support the safety and efficacy of minimally invasive surgery in ventricular cases. Calcified neurocysticercosis continues to be associated with a high burden of disease. Field studies are demonstrating the feasibility of eradication using a combination of mass chemotherapy for human tapeworms and vaccination/treatment of porcine cysticercosis.SummaryNCC remains an important and challenging cause of neurological disease with significant morbidity despite advances in treatment and prevention.

Original languageEnglish (US)
Pages (from-to)246-254
Number of pages9
JournalCurrent opinion in infectious diseases
Issue number3
StatePublished - Jun 1 2022


  • Taenia solium
  • albendazole
  • neurocysticercosis
  • neurosurgery
  • seizures

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases


Dive into the research topics of 'Neurocysticercosis: an update on diagnosis, treatment, and prevention'. Together they form a unique fingerprint.

Cite this